$GEVO

Bloom Paul D sold $50K of GEVO

Bloom Paul D (CEO) sold 35,189 shares of Gevo, Inc. (GEVO) at $1.43 on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bloom Paul D
Published Jun 15, 2026, 9:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 9:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The newest concrete fact is the disclosed sale size, price, and post-transaction holdings; however, the 10b5-1 designation reduces interpretive weight for near-term fundamentals.

02

Market read

This is a routine insider-sale disclosure with limited incremental information for trading beyond monitoring insider activity.

03

What to watch

Traders may over-weight insider sales; the article provides no accompanying operational or financial update to re-rate the business.

Relevance 2/10Novelty 4/10Timing: SEC Form 4 filed 2026-06-15 for a 2026-06-12 sale

Background

The filing is an SEC Form 4 insider transaction for Gevo, Inc., listing the CEO as the reporting insider and noting a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Gevo CEO Paul D Bloom filed an open-market sale of 35,189 shares at $1.4252 on a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction is more about signaling than new fundamentals.

Evidence & confidence

Form 4 insider sales are primary disclosures, but 10b5-1 plans typically reduce the informational content versus discretionary sales.

Market effects

No sector-level catalyst; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is on a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Gevo, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Paul D. Bloom

    CEO and reporting officer/director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.